Submit an Article to Pharmacy HQ     
Please include the author's name, title, and citations.     

COSENTYX- secukinumab injection

Patient Information

Advise the patient to read FDA-approved patient labeling(Medication Guide and Instructions for Use).

Patient Counseling

Instruct patients to read the Medication Guide before starting COSENTYX therapy and to re-read the Medication Guide each time the prescription is renewed.

Advise patients of the potential benefits and risks of COSENTYX.


Inform patients that COSENTYX may lower the ability of their immune system to fight infections. Instruct patients of the importance of communicating any history of infections to the doctor and contacting their doctor if they develop any symptoms of infection[see Warnings and Precautions (5.1)].


Advise patients to seek immediate medical attention if they experience any symptoms of serious hypersensitivity reactions[see Warnings and Precautions (5.4)].

Instruction on Injection Technique

Perform the first self-injection under the supervision of a qualified healthcare professional. If a patient or caregiver is to administer COSENTYX, instruct him/her in injection techniques and assess their ability to inject subcutaneously to ensure the proper administration of COSENTYX[see Medication Guide and Instructions for Use].

Instruct patients or caregivers in the technique of proper syringe and needle disposal, and advise them not to reuse these items. Instruct patients to inject the full amount of COSENTYX (1 or 2 subcutaneous injections of 150 mg) according to the directions provided in the Medication Guide and Instructions for Use. Dispose of needles, syringes and pens in a puncture-resistant container.

Manufactured by:
Novartis Pharmaceuticals Corporation
East Hanover, New Jersey 07936

US License No. 1244



Your use of this website constitutes your agreement to the terms and conditions linked below:
Terms and Conditions | Resources | Sitemap
2017 © Copyright Questions?
Please contact: